Sym004 in Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uz Brussel, Medische Oncologie
Brussels, Belgium
- Uz Gasthuisberg, Digestive Oncology Unit
Brussels, Belgium
- Uz Antwerp, Oncologie
Edegem, Belgium
- Medical Oncology Department, Vall D´hebron University Hospital
Barcelona, Spain
- Servicio de Oncología Médica, Hospital Universitario Virgen del Rocío
Seville, Spain
- Hospital Clínico Universitario de Valencia
Valencia, Spain
- South Texas Accelerated Research Therapeutics (start)
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2010
- Primary completion
- 28 Feb 2015
- Completion
- 31 May 2015
- Last update posted
- 15 Oct 2018
- Registered enrollment
- 111
- Registry id
- NCT01117428
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.